Perioperative Management of Patients with Idiopathic Pulmonary Fibrosis Undergoing Noncardiac Surgery: A Narrative Review

References

• Ryerson CJ, Collard HR. Update on the diagnosis and classification of ILD. Curr Opin Pulm Med. 2013;19(5):453–459. doi:10.1097/MCP.0b013e328363f48d
   PubMed Web of Science ®Google Scholar
• Ley B, Urbania T, Husson G, et al. Code-based diagnostic algorithms for idiopathic pulmonary fibrosis. Case validation and improvement. Ann Am Thorac Soc. 2017;14(6):880–887. doi:10.1513/AnnalsATS.201610-764OC
   PubMed Web of Science ®Google Scholar
• Raghu G, Chen S-Y, Hou Q, Yeh W-S, Collard HR. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old. Eur Respir J. 2016;48(1):179–186. doi:10.1183/13993003.01653-2015
   PubMed Web of Science ®Google Scholar
• Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431–440. doi:10.1164/rccm.201006-0894CI
   PubMed Web of Science ®Google Scholar
• Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979–1991. An analysis of multiple-cause mortality data. Am J Respir Crit Care Med. 1996;153(5):1548–1552. doi:10.1164/ajrccm.153.5.8630600
   PubMed Web of Science ®Google Scholar
• Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc. 2014;11(8):1176–1185. doi:10.1513/AnnalsATS.201404-145OC
   PubMedGoogle Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. doi:10.1164/rccm.2009-040GL
   PubMed Web of Science ®Google Scholar
• Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157(1):199–203. doi:10.1164/ajrccm.157.1.9704130
   PubMed Web of Science ®Google Scholar
• du Bois RM, Weycker D, Albera C, et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011;184(12):1382–1389. doi:10.1164/rccm.201105-0840OC
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med. 2006;174(7):803–809. doi:10.1164/rccm.200604-488OC
   PubMed Web of Science ®Google Scholar
• du Bois RM, Albera C, Bradford WZ, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014;43(5):1421–1429. doi:10.1183/09031936.00131813
   PubMed Web of Science ®Google Scholar
• Robbie H, Daccord C, Chua F, Devaraj A. Evaluating disease severity in idiopathic pulmonary fibrosis. Eur Respir Rev. 2017;26(145):170051. doi:10.1183/16000617.0051-2017
   PubMed Web of Science ®Google Scholar
• Best AC, Meng J, Lynch AM, et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology. 2008;246(3):935–940. doi:10.1148/radiol.2463062200
   PubMed Web of Science ®Google Scholar
• Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med. 2004;98(6):567–573. doi:10.1016/j.rmed.2003.10.015
   PubMed Web of Science ®Google Scholar
• Walsh SLF, Maher TM, Kolb M, et al. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Respir J. 2017;50(2):1700936. doi:10.1183/13993003.00936-2017
   PubMed Web of Science ®Google Scholar
• Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–2082. doi:10.1056/NEJMoa1402584
   PubMed Web of Science ®Google Scholar
• Ley B, Swigris J, Day BM, et al. Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2017;196(6):756–761. doi:10.1164/rccm.201701-0091OC
   PubMed Web of Science ®Google Scholar
• Noble PW, Albera C, Bradford WZ, et al. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational Phase 3 trials. Eur Respir J. 2016;47(1):243–253. doi:10.1183/13993003.00026-2015
   PubMed Web of Science ®Google Scholar
• Patel NM, Kulkarni T, Dilling D, Scholand MB. Preoperative evaluation of patients with interstitial lung disease. Chest. 2019;156(5):826–833. doi:10.1016/j.chest.2019.05.028
   PubMed Web of Science ®Google Scholar
• Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB. In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016;193(10):1161–1167. doi:10.1164/rccm.201508-1632OC
   PubMed Web of Science ®Google Scholar
• Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338–1350. doi:10.1097/ALN.0b013e3181fc6e0a
   PubMed Web of Science ®Google Scholar
• McDowell BJ, Karamchandani K, Lehman EB, Conboy MJ, Carr ZJ. Perioperative risk factors in patients with idiopathic pulmonary fibrosis: a historical cohort study. Can J Anaesth. 2021;68(1):81–91. doi:10.1007/s12630-020-01828-9
   PubMed Web of Science ®Google Scholar
• Sato T, Watanabe A, Kondo H, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149(1):64. doi:10.1016/j.jtcvs.2014.08.086
   PubMed Web of Science ®Google Scholar
• Sato S, Shimizu Y, Goto T, et al. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study. BMC Pulm Med. 2018;18(1):134. doi:10.1186/s12890-018-0703-8
   PubMed Web of Science ®Google Scholar
• Sato T, Kondo H, Watanabe A, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63(3):164–172. doi:10.1007/s11748-014-0487-6
   PubMed Web of Science ®Google Scholar
• Chida M, Ono S, Hoshikawa Y, Kondo T. Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery. Eur J Cardiothorac Surg. 2008;34(4):878–881. doi:10.1016/j.ejcts.2008.07.028
   PubMed Web of Science ®Google Scholar
• Kreuter M, Ehlers-Tenenbaum S, Palmowski K, et al. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One. 2016;11(3):e0151425. doi:10.1371/journal.pone.0151425
   PubMed Web of Science ®Google Scholar
• Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113–1130. doi:10.1183/13993003.02316-2014
   PubMed Web of Science ®Google Scholar
• Kato S, Kitamura H, Hayakawa K, et al. Coronary artery disease and heart failure in patients with idiopathic pulmonary fibrosis. Heart Vessels. 2021;36(8):1151–1158. doi:10.1007/s00380-021-01787-1
   PubMed Web of Science ®Google Scholar
• Izbicki G, Ben-Dor I, Shitrit D, et al. The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med. 2009;103(9):1346–1349. doi:10.1016/j.rmed.2009.03.012
   PubMed Web of Science ®Google Scholar
• Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med. 2007;175(9):875–880. doi:10.1164/rccm.200608-1153CC
   PubMed Web of Science ®Google Scholar
• Seeger W, Adir Y, Barberà JA, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D109–116. doi:10.1016/j.jacc.2013.10.036
   PubMed Web of Science ®Google Scholar
• Song JW, Song JK, Kim DS. Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. Respir Med. 2009;103(2):180–186. doi:10.1016/j.rmed.2008.11.012
   PubMed Web of Science ®Google Scholar
• Fabre A, Treacy A, Lavelle LP, et al. Smoking-related interstitial fibrosis: evidence of radiologic regression with advancing age and smoking cessation. COPD. 2017;14(6):603–609. doi:10.1080/15412555.2017.1378631
   PubMedGoogle Scholar
• Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136(3):772–778. doi:10.1378/chest.08-2776
   PubMed Web of Science ®Google Scholar
• Lee JS, Collard HR, Anstrom KJ, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013;1(5):369–376. doi:10.1016/S2213-2600(13)70105-X
   PubMed Web of Science ®Google Scholar
• Takao S, Masuda T, Yamaguchi K, et al. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery. Medicine. 2019;98(5):e14296. doi:10.1097/MD.0000000000014296
   PubMed Web of Science ®Google Scholar
• Kishaba T, Tamaki H, Shimaoka Y, Fukuyama H, Yamashiro S. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung. 2014;192(1):141–149. doi:10.1007/s00408-013-9530-0
   PubMed Web of Science ®Google Scholar
• Li B, Zhang X, Xu G, et al. Serum prealbumin is a prognostic indicator in idiopathic pulmonary fibrosis. Clin Respir J. 2019;13(8):493–498. doi:10.1111/crj.13050
   PubMed Web of Science ®Google Scholar
• Ikezoe K, Handa T, Tanizawa K, et al. Chronic kidney disease predicts survival in patients with idiopathic pulmonary fibrosis. Respiration. 2017;94(4):346–354. doi:10.1159/000478787
   PubMed Web of Science ®Google Scholar
• Hirji SA, Ramirez-Del Val F, Ejiofor JI, et al. Significance of interstitial lung disease on outcomes following cardiac surgery. Am J Cardiol. 2019;124(7):1133–1139. doi:10.1016/j.amjcard.2019.06.031
   PubMed Web of Science ®Google Scholar
• Choi SM, Lee J, Park YS, et al. Postoperative pulmonary complications after surgery in patients with interstitial lung disease. Respiration. 2014;87(4):287–293. doi:10.1159/000357046
   PubMed Web of Science ®Google Scholar
• Durheim MT, Judy J, Bender S, et al. In-hospital mortality in patients with idiopathic pulmonary fibrosis: a US cohort study. Lung. 2019;197(6):699–707. doi:10.1007/s00408-019-00270-z
   PubMed Web of Science ®Google Scholar
• Rush B, Wiskar K, Berger L, Griesdale D. The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis. Respir Med. 2016;111:72–76. doi:10.1016/j.rmed.2015.12.005
   PubMed Web of Science ®Google Scholar
• Hausman MS Jr., Jewell ES, Engoren M. Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: Does avoiding general anesthesia reduce the risk of postoperative complications? Anesth Analg. 2015;120(6):1405–1412. doi:10.1213/ANE.0000000000000574
   PubMed Web of Science ®Google Scholar
• Honma K, Tango Y, Isomoto H. Perioperative management of severe interstitial pneumonia for rectal surgery: a case report. Kurume Med J. 2007;54(3–4):85–88. doi:10.2739/kurumemedj.54.85
   PubMedGoogle Scholar
• Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. Br Med J. 2000;321(7275):1493–1497. doi:10.1136/bmj.321.7275.1493
   PubMed Web of Science ®Google Scholar
• Hajjar WM, Al-Nassar SA, Al-Sugair GS, et al. Evaluation of safety and efficacy of regional anesthesia compared with general anesthesia in thoracoscopic lung biopsy procedure on patient with idiopathic pulmonary fibrosis. Saudi J Anaesth. 2018;12(1):46–51. doi:10.4103/sja.SJA_265_17
   PubMed Web of Science ®Google Scholar
• Pompeo E, Rogliani P, Cristino B, Schillaci O, Novelli G, Saltini C. Awake thoracoscopic biopsy of interstitial lung disease. Ann Thorac Surg. 2013;95(2):445–452. doi:10.1016/j.athoracsur.2012.10.043
   PubMed Web of Science ®Google Scholar
• Fernandez-Perez ER, Yilmaz M, Jenad H, et al. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest. 2008;133(5):1113–1119. doi:10.1378/chest.07-1481
   PubMed Web of Science ®Google Scholar
• Singh S, Sharma BB, Bairwa M, et al. Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP). Lung India. 2020;37(4):359–378. doi:10.4103/lungindia.lungindia_275_20
   PubMed Web of Science ®Google Scholar
• Kamiya H, Panlaqui OM. Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis. BMJ Open. 2020;10(6):e035420. doi:10.1136/bmjopen-2019-035420
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Iwata H, Shirahashi K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. Eur J Cardiothorac Surg. 2012;41(6):e161–165. doi:10.1093/ejcts/ezs147
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Sakamoto Y, Jo T, et al. Pulmonary disease as a risk factor for transfusion-related acute lung injury. ERJ Open Res. 2021;7(3):00039–2021. doi:10.1183/23120541.00039-2021
   PubMedGoogle Scholar
• Yi E, Lee JH, Lee JH, Chung JH, Lee Y, Lee S. Perioperative risk factors in surgical lung biopsy for the diagnosis of interstitial lung disease: a single-centre experience. ANZ J Surg. 2020;91(3):291–297. doi:10.1111/ans.16112
   PubMed Web of Science ®Google Scholar
• Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis. Chest. 2016;149(5):1205–1214. doi:10.1016/j.chest.2015.12.026
   PubMed Web of Science ®Google Scholar
• Tachikawa R, Tomii K, Ueda H, et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration. 2012;83(1):20–27. doi:10.1159/000329893
   PubMed Web of Science ®Google Scholar
• Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med. 2016;194(3):265–275. doi:10.1164/rccm.201604-0801CI
   PubMed Web of Science ®Google Scholar
• Qiu M, Chen Y, Ye Q. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Respir J. 2018;12(3):1084–1092. doi:10.1111/crj.12631
   PubMed Web of Science ®Google Scholar
• Alam N, Park BJ, Wilton A, et al. Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg. 2007;84(4):1085–1091. doi:10.1016/j.athoracsur.2007.05.053
   PubMed Web of Science ®Google Scholar
• Sato T, Teramukai S, Kondo H, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. Journal of Thoracic and Cardiovascular Surgery. 2014;147(5):1604. doi:10.1016/j.jtcvs.2013.09.050
   PubMed Web of Science ®Google Scholar
• Furuya K, Sakamoto S, Takai Y, Sato N, Matsumoto K, Homma S. Acute exacerbation of idiopathic interstitial pneumonia after nonpulmonary surgery under general anesthesia: a retrospective study. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):156–164.
   PubMed Web of Science ®Google Scholar
• Iwata T, Yoshino I, Yoshida S, et al. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study). Respir Res. 2016;17(1):90. doi:10.1186/s12931-016-0398-4
   PubMed Web of Science ®Google Scholar
• Kanayama M, Mori M, Matsumiya H, et al. Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis. Surg Today. 2020;50(5):469–474. doi:10.1007/s00595-019-01923-5
   PubMed Web of Science ®Google Scholar
• Urushiyama H, Jo T, Hasegawa W, et al. Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: propensity score-matched analysis using a nationwide database in Japan. Respirology. 2021;26(6):590–596. doi:10.1111/resp.14044
   PubMed Web of Science ®Google Scholar
• Mortensen A, Cherrier L, Walia R. Effect of pirfenidone on wound healing in lung transplant patients. Multidiscip Respir Med. 2018;13:13. doi:10.1186/s40248-018-0124-9
   PubMed Web of Science ®Google Scholar
• Yano T, Koga T. [Prophylactic administration of steroid for interstitial pneumonia after pulmonary resection for lung cancer]. Kyobu Geka. 2005;58(1):37–40. Japanese
   PubMedGoogle Scholar
• Ito H, Nakayama H, Yokose T, et al. A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery. Jpn J Clin Oncol. 2020;50(2):198–205. doi:10.1093/jjco/hyz164
   PubMed Web of Science ®Google Scholar
• Hsieh TC, Wu YC, Ding HJ, et al. Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening. Eur J Radiol. 2011;80(3):e510–515. doi:10.1016/j.ejrad.2010.10.030
   PubMed Web of Science ®Google Scholar
• Lee JS, Song JW, Wolters PJ, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J. 2012;39(2):352–358. doi:10.1183/09031936.00050911
   PubMed Web of Science ®Google Scholar
• Sakai T, Planinsic RM, Quinlan JJ, Handley LJ, Kim TY, Hilmi IA. The incidence and outcome of perioperative pulmonary aspiration in a University hospital: a 4-year retrospective analysis. Anesth Analg. 2006;103(4):941–947. doi:10.1213/01.ane.0000237296.57941.e7
   PubMed Web of Science ®Google Scholar
• Rangappa P, Moran JL. Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. Crit Care Resusc. 2009;11(2):102–109.
   PubMed Web of Science ®Google Scholar
• Oda K, Yatera K, Fujino Y, et al. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Respir Investig. 2018;56(1):64–71. doi:10.1016/j.resinv.2017.09.006
   PubMed Web of Science ®Google Scholar
• Chughtai M, Gwam CU, Khlopas A, et al. The incidence of postoperative pneumonia in various surgical subspecialties: a dual database analysis. Surg Technol Int. 2017;30:45–51.
   PubMedGoogle Scholar
• Franquet T, Giménez A, Torrubia S, Sabaté JM, Rodriguez-Arias JM. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol. 2000;10(1):108–113. doi:10.1007/s003300050014
   PubMed Web of Science ®Google Scholar
• Nishimoto K, Fujisawa T, Yoshimura K, et al. The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis. Respirology. 2018;23(5):519–525. doi:10.1111/resp.13219
   PubMed Web of Science ®Google Scholar
• Luo Q, Han Q, Chen X, Xie J, Wu L, Chen R. The diagnosis efficacy and safety of video-assisted thoracoscopy surgery (VATS) in undefined interstitial lung diseases: a retrospective study. J Thorac Dis. 2013;5(3):283–288. doi:10.3978/j.issn.2072-1439.2013.04.12
   PubMed Web of Science ®Google Scholar
• Hill NS, Roberts KR, Preston IR. Postoperative pulmonary hypertension: etiology and treatment of a dangerous complication. Respir Care. 2009;54(7):958–968. doi:10.4187/002013209793800439
   PubMed Web of Science ®Google Scholar
• McGlothlin D, Ivascu N, Heerdt PM. Anesthesia and pulmonary hypertension. Prog Cardiovasc Dis. 2012;55(2):199–217. doi:10.1016/j.pcad.2012.08.002
   PubMed Web of Science ®Google Scholar
• Boonpheng B, Ungprasert P. Risk of venous thromboembolism in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(2):109–114. doi:10.36141/svdld.v35i2.6213
   PubMed Web of Science ®Google Scholar
• Sprunger DB, Olson AL, Huie TJ, et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J. 2012;39(1):125–132. doi:10.1183/09031936.00041411
   PubMed Web of Science ®Google Scholar
• Eltorai AEM, Szabo AL, Antoci V Jr., et al. Clinical effectiveness of incentive spirometry for the prevention of postoperative pulmonary complications. Respir Care. 2018;63(3):347–352. doi:10.4187/respcare.05679
   PubMed Web of Science ®Google Scholar
• Caparelli ML, Shikhman A, Jalal A, Oppelt S, Ogg C, Allamaneni S. Prevention of postoperative pneumonia in noncardiac surgical patients: a prospective study using the national surgical quality improvement program database. Am Surg. 2019;85(1):8–14. doi:10.1177/000313481908500104
   PubMed Web of Science ®Google Scholar
• Ståhl A, Westerdahl E. Postoperative physical therapy to prevent hospital-acquired pneumonia in patients over 80 years undergoing hip fracture surgery-A quasi-experimental study. Clin Interv Aging. 2020;15:1821–1829. doi:10.2147/CIA.S257127
   PubMed Web of Science ®Google Scholar
• Vianello A, Arcaro G, Battistella L, et al. Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis. J Crit Care. 2014;29(4):562–567. doi:10.1016/j.jcrc.2014.03.019
   PubMed Web of Science ®Google Scholar
• Florian J, Watte G, Teixeira PJZ, et al. Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation. Sci Rep. 2019;9(1):9347. doi:10.1038/s41598-019-45828-2
   PubMed Web of Science ®Google Scholar